Last reviewed · How we verify

NCT05214638

Development and Application of Intelligent Assessment System of Longshi Scale

Completed Last updated 31 January 2022
What this trial tests

trial in Stroke in 115 participants. Completed in 31 December 2021.

Timeline
10 September 2021
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorShenzhen Second People's Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment115
Start date10 September 2021
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across China

Conditions studied

Sponsor

Shenzhen Second People's Hospital

Who can join

18 and older, any sex, with Stroke or Disability Physical. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to verify convenience and feasibility of the novel intelligent Longshi assessment system to provide an accurate and convenient evaluation tool for stroke survivors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Evaluation of activities of daily living using an electronic version of the Longshi Scale in patients with stroke: reliability, consistency, and preference.
    Xue K, Li W, Liu F, Liu X, et al · · 2024 · cited 1× · PMID 38750562 · DOI 10.1186/s12911-024-02508-0

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Shenzhen Second People's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05214638.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing